The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharmacovigilance (PV) Outsourcing Market Research Report 2025
Synopsis
The global Pharmacovigilance (PV) Outsourcing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacovigilance (PV) Outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacovigilance (PV) Outsourcing.
Report Scope
The Pharmacovigilance (PV) Outsourcing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacovigilance (PV) Outsourcing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacovigilance (PV) Outsourcing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen
Segment by Type
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)
Segment by Application
Premarketing Clinical Trial
Post-marketing Clinical Practice
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacovigilance (PV) Outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pharmacovigilance (PV) Outsourcing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmacovigilance (PV) Outsourcing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmacovigilance (PV) Outsourcing.
Report Scope
The Pharmacovigilance (PV) Outsourcing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pharmacovigilance (PV) Outsourcing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmacovigilance (PV) Outsourcing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Accenture
C3i Solutions
Clintec
Covance
Deloitte Touche Tohmatsu Limited
ELC Group
Ergomed
iGATE Corporation
iMED Global Corporation
IQVIA
MarksMan Healthcare
Medpace Holdings
Novartis
Oracle Corporation
Parexel
PharmInvent
PrimeVigilance
Pure Drug Safety
Sciformix
SIRO Clinpharm
Symogen
Segment by Type
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)
Segment by Application
Premarketing Clinical Trial
Post-marketing Clinical Practice
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pharmacovigilance (PV) Outsourcing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Contract Research Organizations (CROs)
1.2.3 Business Process Outsourcing (BPOs)
1.3 Market by Application
1.3.1 Global Pharmacovigilance (PV) Outsourcing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Premarketing Clinical Trial
1.3.3 Post-marketing Clinical Practice
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmacovigilance (PV) Outsourcing Market Perspective (2019-2030)
2.2 Pharmacovigilance (PV) Outsourcing Growth Trends by Region
2.2.1 Global Pharmacovigilance (PV) Outsourcing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pharmacovigilance (PV) Outsourcing Historic Market Size by Region (2019-2024)
2.2.3 Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Region (2025-2030)
2.3 Pharmacovigilance (PV) Outsourcing Market Dynamics
2.3.1 Pharmacovigilance (PV) Outsourcing Industry Trends
2.3.2 Pharmacovigilance (PV) Outsourcing Market Drivers
2.3.3 Pharmacovigilance (PV) Outsourcing Market Challenges
2.3.4 Pharmacovigilance (PV) Outsourcing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue
3.1.1 Global Top Pharmacovigilance (PV) Outsourcing Players by Revenue (2019-2024)
3.1.2 Global Pharmacovigilance (PV) Outsourcing Revenue Market Share by Players (2019-2024)
3.2 Global Pharmacovigilance (PV) Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmacovigilance (PV) Outsourcing Revenue
3.4 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio
3.4.1 Global Pharmacovigilance (PV) Outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacovigilance (PV) Outsourcing Revenue in 2023
3.5 Pharmacovigilance (PV) Outsourcing Key Players Head office and Area Served
3.6 Key Players Pharmacovigilance (PV) Outsourcing Product Solution and Service
3.7 Date of Enter into Pharmacovigilance (PV) Outsourcing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmacovigilance (PV) Outsourcing Breakdown Data by Type
4.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Type (2019-2024)
4.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Type (2025-2030)
5 Pharmacovigilance (PV) Outsourcing Breakdown Data by Application
5.1 Global Pharmacovigilance (PV) Outsourcing Historic Market Size by Application (2019-2024)
5.2 Global Pharmacovigilance (PV) Outsourcing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)
6.2 North America Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024)
6.4 North America Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)
7.2 Europe Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024)
7.4 Europe Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)
8.2 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2019-2024)
8.4 Asia-Pacific Pharmacovigilance (PV) Outsourcing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)
9.2 Latin America Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024)
9.4 Latin America Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size (2019-2030)
10.2 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2019-2024)
10.4 Middle East & Africa Pharmacovigilance (PV) Outsourcing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Accenture
11.1.1 Accenture Company Detail
11.1.2 Accenture Business Overview
11.1.3 Accenture Pharmacovigilance (PV) Outsourcing Introduction
11.1.4 Accenture Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.1.5 Accenture Recent Development
11.2 C3i Solutions
11.2.1 C3i Solutions Company Detail
11.2.2 C3i Solutions Business Overview
11.2.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Introduction
11.2.4 C3i Solutions Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.2.5 C3i Solutions Recent Development
11.3 Clintec
11.3.1 Clintec Company Detail
11.3.2 Clintec Business Overview
11.3.3 Clintec Pharmacovigilance (PV) Outsourcing Introduction
11.3.4 Clintec Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.3.5 Clintec Recent Development
11.4 Covance
11.4.1 Covance Company Detail
11.4.2 Covance Business Overview
11.4.3 Covance Pharmacovigilance (PV) Outsourcing Introduction
11.4.4 Covance Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.4.5 Covance Recent Development
11.5 Deloitte Touche Tohmatsu Limited
11.5.1 Deloitte Touche Tohmatsu Limited Company Detail
11.5.2 Deloitte Touche Tohmatsu Limited Business Overview
11.5.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Introduction
11.5.4 Deloitte Touche Tohmatsu Limited Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.5.5 Deloitte Touche Tohmatsu Limited Recent Development
11.6 ELC Group
11.6.1 ELC Group Company Detail
11.6.2 ELC Group Business Overview
11.6.3 ELC Group Pharmacovigilance (PV) Outsourcing Introduction
11.6.4 ELC Group Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.6.5 ELC Group Recent Development
11.7 Ergomed
11.7.1 Ergomed Company Detail
11.7.2 Ergomed Business Overview
11.7.3 Ergomed Pharmacovigilance (PV) Outsourcing Introduction
11.7.4 Ergomed Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.7.5 Ergomed Recent Development
11.8 iGATE Corporation
11.8.1 iGATE Corporation Company Detail
11.8.2 iGATE Corporation Business Overview
11.8.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Introduction
11.8.4 iGATE Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.8.5 iGATE Corporation Recent Development
11.9 iMED Global Corporation
11.9.1 iMED Global Corporation Company Detail
11.9.2 iMED Global Corporation Business Overview
11.9.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Introduction
11.9.4 iMED Global Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.9.5 iMED Global Corporation Recent Development
11.10 IQVIA
11.10.1 IQVIA Company Detail
11.10.2 IQVIA Business Overview
11.10.3 IQVIA Pharmacovigilance (PV) Outsourcing Introduction
11.10.4 IQVIA Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.10.5 IQVIA Recent Development
11.11 MarksMan Healthcare
11.11.1 MarksMan Healthcare Company Detail
11.11.2 MarksMan Healthcare Business Overview
11.11.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Introduction
11.11.4 MarksMan Healthcare Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.11.5 MarksMan Healthcare Recent Development
11.12 Medpace Holdings
11.12.1 Medpace Holdings Company Detail
11.12.2 Medpace Holdings Business Overview
11.12.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Introduction
11.12.4 Medpace Holdings Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.12.5 Medpace Holdings Recent Development
11.13 Novartis
11.13.1 Novartis Company Detail
11.13.2 Novartis Business Overview
11.13.3 Novartis Pharmacovigilance (PV) Outsourcing Introduction
11.13.4 Novartis Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.13.5 Novartis Recent Development
11.14 Oracle Corporation
11.14.1 Oracle Corporation Company Detail
11.14.2 Oracle Corporation Business Overview
11.14.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Introduction
11.14.4 Oracle Corporation Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.14.5 Oracle Corporation Recent Development
11.15 Parexel
11.15.1 Parexel Company Detail
11.15.2 Parexel Business Overview
11.15.3 Parexel Pharmacovigilance (PV) Outsourcing Introduction
11.15.4 Parexel Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.15.5 Parexel Recent Development
11.16 PharmInvent
11.16.1 PharmInvent Company Detail
11.16.2 PharmInvent Business Overview
11.16.3 PharmInvent Pharmacovigilance (PV) Outsourcing Introduction
11.16.4 PharmInvent Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.16.5 PharmInvent Recent Development
11.17 PrimeVigilance
11.17.1 PrimeVigilance Company Detail
11.17.2 PrimeVigilance Business Overview
11.17.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Introduction
11.17.4 PrimeVigilance Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.17.5 PrimeVigilance Recent Development
11.18 Pure Drug Safety
11.18.1 Pure Drug Safety Company Detail
11.18.2 Pure Drug Safety Business Overview
11.18.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Introduction
11.18.4 Pure Drug Safety Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.18.5 Pure Drug Safety Recent Development
11.19 Sciformix
11.19.1 Sciformix Company Detail
11.19.2 Sciformix Business Overview
11.19.3 Sciformix Pharmacovigilance (PV) Outsourcing Introduction
11.19.4 Sciformix Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.19.5 Sciformix Recent Development
11.20 SIRO Clinpharm
11.20.1 SIRO Clinpharm Company Detail
11.20.2 SIRO Clinpharm Business Overview
11.20.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Introduction
11.20.4 SIRO Clinpharm Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.20.5 SIRO Clinpharm Recent Development
11.21 Symogen
11.21.1 Symogen Company Detail
11.21.2 Symogen Business Overview
11.21.3 Symogen Pharmacovigilance (PV) Outsourcing Introduction
11.21.4 Symogen Revenue in Pharmacovigilance (PV) Outsourcing Business (2019-2024)
11.21.5 Symogen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
